Vaishnavi Kambhampati
4PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Nov 20, 2025
Hydronidone Mitigates Pulmonary Fibrosis by Regulating the TGF-β/Smad2/3 Axis in in Vitro and in Vivo Models.Sai Balaji Andugulapati, Vaishnavi Kambhampati, Harish Kumar B
|Oct 06, 2025
Discovery of 2-(4-Ureido-piperidin-1-yl)-4-morpholinothieno [3,2-D] Pyrimidines as Orally Bioavailable Phosphoinositide-3-Kinase Inhibitors with In Vitro and In Vivo Antitumor Efficacy in Triple-Negative Breast Cancer.Shabber Mohammed, Shabu Thakur, Diksha Manhas
|Sep 19, 2025
Design and Synthesis of Novel Pirfenidone Analogues for Targeting Fibroblast Differentiation via Transforming Growth Factor-β/Smad Pathway Using In Vitro and In Vivo Models.Laxman D Nandawadekar, Vaishnavi Kambhampati, Sai Kiran Kunuru
|Jun 19, 2025
NARI-29: A Novel Epalrestat Derivative Attenuates Pulmonary Fibrosis by Modulating the TGF-β/Smad Signaling.Sai Balaji Andugulapati, Vaishnavi Kambhampati, Abhisheik Eedara
Pageof 1
Frequent Collaborators
3 joint publications
Sai Balaji Andugulapati
2 joint publications
Abhisheik Eedara
1 joint publications
D Srinivasa Reddy
1 joint publications
Shabber Mohammed
1 joint publications
Santosh K Guru
1 joint publications
Ramajayan Pandian
1 joint publications
Boobalan Gopu
1 joint publications
Ram A Vishwakarma
1 joint publications
Utpal Nandi
1 joint publications
Sandip B Bharate
